Loading...

IGEA Pharma N.V.

IGPH.SW•SIX
Healthcare
Medical - Diagnostics & Research
CHF0.002
CHF-0.00(-25.00%)

IGEA Pharma N.V. (IGPH.SW) Stock Overview

Explore IGEA Pharma N.V.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap505.5K
P/E Ratio-0.05
EPS (TTM)$-0.03
ROE-3.20%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

IGPH.SW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of IGEA Pharma N.V. (IGPH.SW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.05 and a market capitalization of 505.5K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Stats data is not available for IGPH.SWStats details for IGPH.SW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for IGPH.SWAnalyst Recommendations details for IGPH.SW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

IGEA Pharma N.V. commercializes health-tech and med-tech products and devices in in the United States and the Netherlands. It offers Alz1, an at-home lab test kit to measure non-bound copper in the blood; dietary supplement products to reduce blood heavy metals content under the Alz1 Tab brand; and COVID19 rapid test for the detection of IgM and IgG SARS-CoV-2 related antibodies. The company also provides dry aerosol generators for air and inanimate environmental surfaces sanitization, as well as air sterilization and purification devices. In addition, it engages in laboratory analysis. The company was incorporated in 2015 and is headquartered in Hoofddorp, the Netherlands.

CEO

Pierpaolo Cerani

Employees

1

Headquarters

Siriusdreef 17, Hoofddorp

Founded

2018

Frequently Asked Questions

;